Subject: Neuropsychopharmacology Volume 31 Number 9 - Table of Contents alert

From: "NeuropsychopharmacologyAlert"<[email-masked]>
Date: Mon, 21 Aug 2006 13:02:59 -0400 (EDT)

Accessibility statement Jump to content

| NATURE.COM [email-masked] NATUREJOBS NATUREEVENTS ABOUT NPG

MY ACCOUNT|E-ALERTS|SUBSCRIBE|REGISTER

TABLE OF CONTENTS

| |

Volume 31, Issue 9 (September 2006)
ACNP Task Force Report
Original Articles

Recommend to your library

Neuropsychopharmacology - official journal of the American College of Neuropsychopharmacology. View a full issue FREE online now.

ACNP Task Force Report

Top

Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

A John Rush, Helena C Kraemer, Harold A Sackeim, Maurizio Fava, Madhukar H Trivedi, Ellen Frank, Philip T Ninan, Michael E Thase, Alan J Gelenberg, David J Kupfer, Darrel A Regier, Jerrold F Rosenbaum, Oakley Ray and Alan F Schatzberg

Neuropsychopharmacology 2006 31: 1841-1853; advance online publication, June 21, 2006; 10.1038/sj.npp.1301131

Abstract | Full Text

Original Articles

Top

Dissociation between In Vivo Occupancy and Functional Antagonism of Dopamine D2 Receptors: Comparing Aripiprazole to Other Antipsychotics in Animal Models

Sridhar Natesan, Greg E Reckless, José N Nobrega, Paul J Fletcher and Shitij Kapur

Neuropsychopharmacology 2006 31: 1854-1863; advance online publication, November 30, 2005; 10.1038/sj.npp.1300983

Abstract | Full Text

Multidose Risperidone Treatment Evaluated in a Rodent Model of Tardive Dyskinesia

Xue-Min Gao, Thomas Cooper, Raymond F Suckow and Carol A Tamminga

Neuropsychopharmacology 2006 31: 1864-1868; advance online publication, November 23, 2005; 10.1038/sj.npp.1300975

Abstract | Full Text

Antipsychotic-Like vs Cataleptogenic Actions in Mice of Novel Antipsychotics Having D2 Antagonist and 5-HT1A Agonist Properties

Laurent Bardin, Mark S Kleven, Catherine Barret-Grévoz, Ronan Depoortère and Adrian Newman-Tancredi

Neuropsychopharmacology 2006 31: 1869-1879; advance online publication, October 19, 2005; 10.1038/sj.npp.1300940

Abstract | Full Text

Glial–Neuronal Interactions are Impaired in the Schizophrenia Model of Repeated MK801 Exposure

Daniel Kondziella, Eiliv Brenner, Elvar M Eyjolfsson, Katarina Ryden Markinhuhta, Maria L Carlsson and Ursula Sonnewald

Neuropsychopharmacology 2006 31: 1880-1887; advance online publication, December 14, 2005; 10.1038/sj.npp.1300993

Abstract | Full Text

Chronic Olanzapine Treatment Causes Differential Expression of Genes in Frontal Cortex of Rats as Revealed by DNA Microarray Technique

S Hossein Fatemi, Teri J Reutiman, Timothy D Folsom, Christopher Bell, Lisa Nos, Peter Fried, David A Pearce, Sushmita Singh, David P Siderovski, Francis S Willard and Mitsunori Fukuda

Neuropsychopharmacology 2006 31: 1888-1899; advance online publication, January 11, 2006; 10.1038/sj.npp.1301002

Abstract | Full Text

Actions of Novel Antipsychotic Agents on Apomorphine-Induced PPI Disruption: Influence of Combined Serotonin 5-HT1A Receptor Activation and Dopamine D2 Receptor Blockade

Agnès L Auclair, Mark S Kleven, Joël Besnard, Ronan Depoortère and Adrian Newman-Tancredi

Neuropsychopharmacology 2006 31: 1900-1909; advance online publication, January 18, 2006; 10.1038/sj.npp.1301015

Abstract | Full Text

Early-Life Immune Challenge: Defining a Critical Window for Effects on Adult Responses to Immune Challenge

Sarah J Spencer, Sheilagh Martin, Abdeslam Mouihate and Quentin J Pittman

Neuropsychopharmacology 2006 31: 1910-1918; advance online publication, January 4, 2006; 10.1038/sj.npp.1301004

Abstract | Full Text

Chronic Administration of 13-Cis-Retinoic Acid Increases Depression-Related Behavior in Mice

Kally C O'Reilly, Jason Shumake, F Gonzalez-Lima, Michelle A Lane and Sarah J Bailey

Neuropsychopharmacology 2006 31: 1919-1927; advance online publication, January 4, 2006; 10.1038/sj.npp.1300998

Abstract | Full Text

Big Dynorphin, a Prodynorphin-Derived Peptide Produces NMDA Receptor-Mediated Effects on Memory, Anxiolytic-Like and Locomotor Behavior in Mice

Alexander Kuzmin, Nather Madjid, Lars Terenius, Sven Ove Ogren and Georgy Bakalkin

Neuropsychopharmacology 2006 31: 1928-1937; advance online publication, November 16, 2005; 10.1038/sj.npp.1300959

Abstract | Full Text

Effects of Atypical Antipsychotic Drugs on Intralipid Intake and Cocaine-Induced Hyperactivity in Rats

Abegale W Hartfield, Nicholas A Moore and Peter G Clifton

Neuropsychopharmacology 2006 31: 1938-1945; advance online publication, November 2, 2005; 10.1038/sj.npp.1300949

Abstract | Full Text

Methylphenidate Administration to Adolescent Rats Determines Plastic Changes on Reward-Related Behavior and Striatal Gene Expression

Walter Adriani, Damiana Leo, Dario Greco, Monica Rea, Umberto di Porzio, Giovanni Laviola and Carla Perrone-Capano

Neuropsychopharmacology 2006 31: 1946-1956; advance online publication, November 23, 2005; 10.1038/sj.npp.1300962

Abstract | Full Text

Involvement of κ/Dynorphin System in WIN 55,212-2 Self-Administration in Mice

Victoria Mendizábal, Andreas Zimmer and Rafael Maldonado

Neuropsychopharmacology 2006 31: 1957-1966; advance online publication, November 16, 2005; 10.1038/sj.npp.1300957

Abstract | Full Text

Kappa-Opioid Agonist U69593 Potentiates Locomotor Sensitization to the D2/D3 Agonist Quinpirole: Pre- and Postsynaptic Mechanisms

Melissa L Perreault, Dawn Graham, Liane Bisnaire, Jennifer Simms, Scott Hayton and Henry Szechtman

Neuropsychopharmacology 2006 31: 1967-1981; advance online publication, October 12, 2005; 10.1038/sj.npp.1300938

Abstract | Full Text

Tryptophan Hydroxylase-1 Gene Variants Associate with a Group of Suicidal Borderline Women

Ghazal Zaboli, Rinat Gizatullin, Åsa Nilsonne, Alexander Wilczek, Erik G Jönsson, Ewa Ahnemark, Marie Åsberg and Rosario Leopardi

Neuropsychopharmacology 2006 31: 1982-1990; advance online publication, February 22, 2006; 10.1038/sj.npp.1301046

Abstract | Full Text

Occupancy of Striatal and Extrastriatal Dopamine D2 Receptors by Clozapine and Quetiapine

Robert M Kessler, M Sib Ansari, Patrizia Riccardi, Rui Li, Karuna Jayathilake, Benoit Dawant and Herbert Y Meltzer

Neuropsychopharmacology 2006 31: 1991-2001; advance online publication, May 31, 2006; 10.1038/sj.npp.1301108

Abstract | Full Text

DTNBP1 (Dysbindin) Gene Variants Modulate Prefrontal Brain Function in Healthy Individuals

Andreas J Fallgatter, Martin J Herrmann, Christa Hohoff, Ann-Christine Ehlis, Tomasz A Jarczok, Christine M Freitag and Jürgen Deckert

Neuropsychopharmacology 2006 31: 2002-2010; advance online publication, January 11, 2006; 10.1038/sj.npp.1301003

Abstract | Full Text

Antipsychotic Effects on Prepulse Inhibition in Normal 'Low Gating' Humans and Rats

Neal R Swerdlow, Jo Talledo, Ashley N Sutherland, Derek Nagy and Jody M Shoemaker

Neuropsychopharmacology 2006 31: 2011-2021; advance online publication, February 8, 2006; 10.1038/sj.npp.1301043

Abstract | Full Text

The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia

Terry E Goldberg, Richard E Straub, Joseph H Callicott, Ahmad Hariri, Venkata S Mattay, Llewellyn Bigelow, Richard Coppola, Michael F Egan and Daniel R Weinberger

Neuropsychopharmacology 2006 31: 2022-2032; advance online publication, March 22, 2006; 10.1038/sj.npp.1301049

Abstract | Full Text

Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

Richard S E Keefe, Robert M Bilder, Philip D Harvey, Sonia M Davis, Barton W Palmer, James M Gold, Herbert Y Meltzer, Michael F Green, Del D Miller, Jose M Canive, Lawrence W Adler, Theo C Manschreck, Marvin Swartz, Robert Rosenheck, Diana O Perkins, Trina M Walker, T Scott Stroup, Joseph P McEvoy and Jeffrey A Lieberman

Neuropsychopharmacology 2006 31: 2033-2046; advance online publication, April 19, 2006; 10.1038/sj.npp.1301072

Abstract | Full Text

Further Evidence for an Association of 5-HTTLPR with Intensity Dependence of Auditory-Evoked Potentials

Tilman Hensch, Hanna-Linn Wargelius, Ulf Herold, Klaus-Peter Lesch, Lars Oreland and Burkhard Brocke

Neuropsychopharmacology 2006 31: 2047-2054; advance online publication, January 18, 2006; 10.1038/sj.npp.1301020

Abstract | Full Text

Is there Epidemiological Evidence to Support the Idea that a Cocaine Dependence Syndrome Emerges Soon after Onset of Cocaine Use?

Beth A Reboussin and James C Anthony

Neuropsychopharmacology 2006 31: 2055-2064; advance online publication, February 8, 2006; 10.1038/sj.npp.1301037

Abstract | Full Text

Estrogen Treatment Effects on Anticholinergic-Induced Cognitive Dysfunction in Normal Postmenopausal Women

Julie Dumas, Catherine Hancur-Bucci, Magdalena Naylor, Cynthia Sites and Paul Newhouse

Neuropsychopharmacology 2006 31: 2065-2078; advance online publication, February 15, 2006; 10.1038/sj.npp.1301042

Abstract | Full Text

Hormone Treatment Gives No Benefit Against Cognitive Changes Caused by Acute Sleep Deprivation in Postmenopausal Women

Maija Karakorpi, Paula Alhola, Anna Sofia Urrila, Mervi Kylmälä, Raija Portin, Nea Kalleinen and Päivi Polo-Kantola

Neuropsychopharmacology 2006 31: 2079-2088; advance online publication, March 15, 2006; 10.1038/sj.npp.1301056

Abstract | Full Text

To learn more about submitting your paper to Neuropsychopharmacology, read the journal's Instructions to Authors online.

ADVERTISEMENT

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

© 2006 Nature Publishing Group